middle.news
Saluda Medical Secures FDA Approval for CAP24 Paddle Lead
9:29am on Tuesday 30th of June, 2026 AEST
•
Healthcare
Read Story
Saluda Medical Secures FDA Approval for CAP24 Paddle Lead
9:29am on Tuesday 30th of June, 2026 AEST
Key Points
FDA approves CAP24 paddle lead for US market
Targets neurosurgeons and orthopedic surgeons covering 30% of US SCS implants
First paddle lead engineered for closed-loop neuromodulation
Phased US launch planned from second half of 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Saluda Medical, (ASX:SLD)
OPEN ARTICLE